Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease

R. Yarchoan, R. V. Thomas, J. Grafman, A. Wichman, M. Dalakas, N. McAtee, G. Berg, M. Fischl, C. F. Perno, R. W. Klecker, A. Buchbinder, S. Tay, S. M. Larson, C. E. Myers, S. Broder

Research output: Contribution to journalArticle

Abstract

3'-Azido-2',3'-dideoxythymidine (AZT) has been administered to 7 patients with human immunodeficiency virus-associated neurological disease: 3 with dementia, 2 with peripheral neuropathy, 1 with dementia and peripheral neuropathy, and 1 with T-10 paraplegia. Six of the patients showed improvement in their neurological dysfunction on being administered AZT, as assessed by clinical evaluation, neuropsychological testing, nerve conduction studies, and/or positron emission tomographic scans. Three of these 6 patients showed sustained improvement 5 to 18 months after the initiation of AZT therapy. These results suggest that certain human immunodeficiency virus-associated neurological abnormalities are at least partially reversible following the administration of antiretroviral therapy and provide a rationale for further studies using antiretroviral chemotherapy.

Original languageEnglish
JournalAnnals of Neurology
Volume23
Issue numberSUPPL.
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease'. Together they form a unique fingerprint.

  • Cite this

    Yarchoan, R., Thomas, R. V., Grafman, J., Wichman, A., Dalakas, M., McAtee, N., Berg, G., Fischl, M., Perno, C. F., Klecker, R. W., Buchbinder, A., Tay, S., Larson, S. M., Myers, C. E., & Broder, S. (1988). Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease. Annals of Neurology, 23(SUPPL.).